Medicine / D-0016-2027
U.S. Food and Drug AdministrationD-0016-2027
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by:…
Class II Ohio named in distribution
Status: Ongoing
What was recalled
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01
Recalling firm
J&J INNOVATIVE MEDICINE
Reason for recall
Presence of particulate matter.
Where it went
OH
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.